朗玛信息：2025年第一季度研发费用同比下降32.55%

Core Viewpoint - The company reported a 32.55% year-on-year decrease in R&D expenses for the first quarter of 2025, primarily due to a strategic focus on medical artificial intelligence development, leading to optimization of existing business and personnel [1] Summary by Categories R&D Expenses - The R&D expenses for the first quarter of 2025 amounted to a significant reduction compared to the same period in 2024, with a decrease of 32.55% [1] - The components of R&D expenses include leasing costs, depreciation, custody fees, and labor costs [1] Strategic Focus - The company has concentrated its resources on the development of medical artificial intelligence, which has influenced the reduction in R&D expenses [1] - Optimization of existing business and personnel was a key factor in the decrease of R&D expenses [1]